Relapsing vs Progressive Multiple Sclerosis

admin avatar

by admin |

Share this article:

Share article via email

Recently, the U.S. Food and Drug Administration (FDA) gave priority review to a request to approve Ocrevus (ocrelizumab) as a treatment for both relapsing and primary progressive MS.

But each form of the disease has its own peculiarities.

In this video from msworldinc, watch Dr. Daniel Kantor discussing with Dr. Jay Rosenberg, Dr. Jonathan Calkwood, Dr. Heidi Crayton,and Dr. Samuel Hunter the differences between relapsing and progressive forms of multiple sclerosis (MS).

Learn more about the 1st potential therapy for primary progressive MS, Ocrelizumab here.

Multiple Sclerosis News Today is strictly a news and information website about the disease. It does not provide medical advice, diagnosis or treatment. This content is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition. Never disregard professional medical advice or delay in seeking it because of something you have read on this website.

The Multiple Sclerosis Podcast


Survey Icon

Video